Vascular thrombosis, a important medical issue, calls for prompt removal of blood clots to revive blood movement. A standard intervention approach is intravenous infusion of tissue plasminogen activator (tPA), but its brief 50 %-daily life and susceptibility to inactivation by inhibitors pose problems, bringing about large doses that cause bleeding